Tetramethylammonium Ion

Tetramethylammonium Ion

SCHEMBL1174055

C#C[B-](c1ccc(-c2ccccc2)cc1)(c1ccc(-c2ccccc2)cc1)c1ccc(-c2ccccc2)cc1.C[N+](C)(C)C

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
PYCR1 P32322 1/20 0.37
TAAR1 Q96RJ0 3/20 0.34
MAPK1 P28482 1/20 0.34
CYP3A4 P08684 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MMP3 P08254 1/20 0.34
BCL2L1 Q07817 1/20 0.34
LPL P06858 1/20 0.33
LIPG Q9Y5X9 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC22A2 O15244 1/20 0.32
SLC22A1 O15245 1/20 0.32
SLC22A3 O75751 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetramethylammonium Ion SCHEMBL1173476 0.89 APOBEC3A (0.33) ALDH1A1TDP1
SCHEMBL8757073 0.79 ALDH1A1 (0.37) ALDH1A1
Lithium Ion SCHEMBL9003425 0.77 ALDH1A1 (0.35) ALDH1A1
Toluene SCHEMBL18245453 0.72 LMNA (0.48) TDP1SMN1; SMN2
Tannin Pyrogallol SCHEMBL27920664 0.68 ALDH1A1 (0.82) CYP1A2ALDH1A1CYP1A1CYP1B1TAAR1
Biphenyl SCHEMBL8358517 0.66 ALDH1A1 (0.64) CYP1A2ALDH1A1CYP1A1CYP1B1PYCR1
SCHEMBL18674172 0.65 ALDH1A1 (0.90) CYP1A2ALDH1A1CYP1A1CYP1B1TAAR1
SCHEMBL1991754 0.65 ALDH1A1 (0.90) CYP1A2ALDH1A1CYP1A1CYP1B1TAAR1
SCHEMBL827097 0.65 ALDH1A1 (0.90) CYP1A2ALDH1A1CYP1A1CYP1B1TAAR1
Tannin Pyrogallol SCHEMBL21448 0.65 ALDH1A1 (0.90) CYP1A2ALDH1A1CYP1A1CYP1B1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436173-B2 Boron compounds, their production processes, and functional electronic devices using same KYOTO UNIVERSITY (JP) 2013-05-07 US disclosed
US-20110046372-A1 NOVEL BORON COMPOUNDS, THEIR PRODUCTION PROCESSES, AND FUNCTIONAL ELECTRONIC DEVICES USING SAME Kyoto University and Nippon Shokubai Co., LTD. 2011-02-24 US disclosed
EP-2233490-A1 NOVEL BORON COMPOUND, METHOD FOR PRODUCING THE SAME, AND FUNCTIONAL ELECTRONIC DEVICE USING THE SAME Kyoto University (JP) 2010-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046372-A1 NOVEL BORON COMPOUNDS, THEIR PRODUCTION PROCESSES, AND FUNCTIONAL ELECTRONIC DEVICES USING SAME ETFB, SLC40A1, SLC19A1 CYP1A2 3205/4885ALDH1A1 3015/4885CYP1A1 2089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.